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NEW & NOTEWORTHY
Prolonged, uninterrupted sitting in healthy desk workers reduces cerebral blood flow. However, this reduction in cerebral blood flow is offset when frequent, short-duration walking breaks are incorporated into this sitting period. For those who engage in long periods of sedentary behaviour, chronically breaking up these sitting periods with frequent active break strategies may have important implications for cerebrovascular health, however further research should explore this hypothesis.
INTRODUCTION
Sedentary behaviour (SB), defined as any waking behaviour in a sitting, reclining or lying posture (51) , is an independent risk factor for multiple preventable diseases including cardiovascular disease and stroke (8, 11, 24, 57) and both cardiovascular and all-cause mortality (8, 57) . Greater SB is also linked to impaired brain structure and function, which may contribute to cognitive decline and the development of neurodegenerative diseases such as dementia (53) .
Indeed, increased SB is associated with lower cognitive function (17) . Understanding how SB affects the brain is therefore of great importance to delineate the association between cognition and SB.
The delivery and regulation of cerebral blood flow (CBF) is vital for normal brain function and survival (54) . Cerebrovascular function describes the mechanisms regulating CBF to maintain constant cerebral perfusion (56) , preventing the risk of ischemic brain injury and damage (52, 53, 56) . Acute reductions in CBF are linked to impaired cognitive functioning (6, 23) , whilst in the longer term impaired cerebrovascular function is implicit in neurodegenerative diseases including dementia, Alzheimer's disease and stroke (19, 22, 58) . SB impairs peripheral blood flow, vascular function (36, 48) and glycemic control (15, 31) . Whether a similar reduction occurs in cerebrovascular blood flow and function is unknown.
Alternatively, breaking up sitting with short bouts of low-intensity physical activity (PA) can prevent these detriments to vascular health and metabolic control (15, 31, 48) . Furthermore, the frequency of these PA breaks appears to be an important modulator of these responses, as regularly breaking prolonged sitting with short PA bouts is more effective than a single PA bout at lowering postprandial glucose and insulin concentrations (31) . Cerebrovascular function increases during exercise or following chronic exercise training (26, 28, 33) , additionally short 5 duration low-intensity walking bouts can also elevate CBF (20, 27) . Accordingly, regularly breaking up sitting with PA breaks may have beneficial effects on CBF and cerebrovascular function; however this is unknown.
This study explored the acute CBF and cerebrovascular function responses to prolonged, uninterrupted sitting, and assessed the cerebrovascular effects of breaking up prolonged sitting with short bouts of light intensity PA. We hypothesised that prolonged sitting would reduce CBF and impair cerebrovascular function, but this would be attenuated with light intensity PA breaks and that, in line with previous work, a more frequent PA break strategy would be more effective at preventing any impairment in cerebrovascular function.
MATERIAL AND METHODS

Participants
Fifteen (10 male) healthy desk workers employed in office and administrative jobs volunteered and written informed consent was obtained. Participants were recruited via advertising emails and posters which were distributed to University mailing lists, and by using newspaper advertisements. Participants were screened for exclusion criteria including: taking medication, smoker, BMI >35 or <18 kg•m -2 , use of hormone-based contraception and diagnosis of cerebrovascular, cardiovascular or metabolic disease. Study procedures were approved by Liverpool John Moores University Ethics Committee and adhered to the Declaration of Helsinki.
Study design
Participants attended the temperature controlled (20-22 °C) laboratory at the same time of day (7.00-9.00 am) on three separate occasions. Testing procedures were the same across each test day ( Figure 1 ). After arrival and 20-min supine rest, middle cerebral artery blood flow velocity (MCAv) and cerebrovascular carbon dioxide reactivity (CVR) were assessed. Participants were then seated and underwent measures of seated MCAv and cerebral autoregulation (CA).
Following baseline measurements participants completed, in a randomised order: a) 4-hr uninterrupted sitting (SIT), b) 4-hr sitting+2-min light-intensity treadmill walking breaks every 30-min (2WALK) or, c) 4-hr sitting+8-min light intensity treadmill walking breaks every 120-min (8WALK). The measurement of seated MCAv was repeated immediately after each 4-hr intervention. MCAv was assessed while seated to assess the posture of interest, sitting, and to prevent the effects of moving to a supine posture altering hemodynamics. Participants then returned to a supine posture and supine MCAv and CVR were assessed, followed by CA. Heart rate (HR) and MCAv were recorded immediately prior to and during each walking break.
Study procedures
Prior to each visit participants were instructed to avoid strenuous exercise for 24-hr, to complete an overnight fast and abstinence from caffeine and alcohol. Women were assessed in the follicular phase of the menstrual cycle (days 1-7). Participants completed the International Physical Activity Questionnaire (Long form, IPAQ) (9) to determine habitual PA (14) and SB (39) . Given the duration of testing, participants were given low calorie, low fat, standardised snacks at specified time points (Figure 1 ). Following baseline tests, participants were given a breakfast cereal bar (Belvita Milk and Cereal Breakfast Biscuits, 220kcal, 33.6g carbohydrate, 7.2g fat, 3.6g protein) and a banana after 2-hr (~100kcal, ~27.0g carbohydrate, ~0.3g fat, ~1.0g protein). Water was available to drink ad libitum.
Interventions
Uninterrupted sitting (SIT).
Participants remained seated at a desk for 4-hr and were permitted to perform low cognitively demanding desk-based activities such as reading, watching TV, surfing the internet or completing simple work tasks on a computer. Participants were prevented from standing or walking, with the exception of visiting the toilet (walking distance of ~7.5 m;
on average participants visited the toilet once during each intervention), and from making vigorous movements. Participants were supervised at all times to ensure these conditions were adhered to.
2-min walking breaks (2WALK).
Sitting was interrupted every 30-min with a 2-min light intensity treadmill walking break. Consequently, eight breaks were completed, totalling 16-min of activity. This break strategy was selected based on recommendations from the The Sedentary
Behaviour and Obesity Expert Working Group (7) which advises taking a break from sitting every 30-min. Walking was performed on a treadmill with no gradient (Run XT, Technogym, Italy) at a self-selected, habitual walking speed to represent an ecologically valid PA break that could be performed in a working environment. Walking speed was determined during a familiarisation session prior to the first experimental trial began and this speed was kept consistent for all walking breaks. Walking intensity was assessed during each PA bout using the rating of perceived exertion (RPE) and HR.
8-min walking breaks (8WALK).
Sitting was interrupted every 120-min with an 8-min light intensity walk, using the same walking speed as previously described. Consequently, two breaks were completed, totalling 16-min of activity. Therefore, the total duration of PA performed in both walking break conditions was identical. This less frequent break strategy was based on recommendations that interventions to break up sitting must be feasible (5), which a high frequency breaks strategy may not be when translated into practise.
Measurements
All physiological data measurements were continuously acquired at 50 Hz using an analog-todigital convertor (PowerLab ML880, ADInstruments, Colorado Springs, Colorado, USA) and displayed in real time on a computer with commercially available software (LabChart Version 7.0, ADInstruments). based on the signal depth, peak and mean blood flow velocity as previously described (54) .
Middle cerebral artery blood flow velocity (MCAv
Once optimal signals had been obtained, the transducers were secured into position and the signal parameters were recorded to ensure within-subject consistency between tests.
Additionally, photographs were taken of the probe positions as a reference for the acoustic window for subsequent visits. The sonographer had a between-day coefficient of variation of 7.8% for the MCAv.
Mean MCAv was calculated from the envelope of the velocity tracing using a weighted mean 
Cerebrovascular carbon dioxide reactivity (CVR). Maintenance of adequate CBF is influenced
by the brain's ability to alter blood flow in response to changes in partial pressure of arterial carbon dioxide, termed CVR (56) . Participants were instrumented with a face mask with a twoway non-rebreathing valve (MLA1028, ADInstruments, Colorado Springs, Colorado, USA). A Douglas bag filled with a 5% carbon dioxide (CO2) mixture and fitted with a three-way valve, enabled the breathing circuit to be alternated between ambient air and the contents of the Douglas bag. Breath-by-breath CO2 was sampled using a calibrated gas analyser (Ml206, ADInstruments) and the pressure of end-tidal carbon dioxide (PETCO2) was calculated in LabChart with correction for the daily barometric pressure. After a 1-min baseline, participants were coached through a voluntary hyperventilation for 3-min or until PETCO2 was reduced to 20 mmHg (whichever was achieved first). Immediately afterwards the valve on the Douglas bag was switched so participants inhaled the 5% CO2 mixture. Simultaneously, participants were instructed to return their respiratory rate to normal whilst breathing the 5% CO2 mixture Simultaneously, during the baseline and CO2 breathing measurements, arterial diameter and blood flow of the left common carotid artery (CCA) were acquired using a 10-MHz multifrequency linear array probe, attached to high resolution ultrasound machine (T3000; Terason, Burlington, MA, USA). Using ultrasound to assess the dilation of larger extracranial neck vessels during CO2 alterations provides another means to monitor reactivity and vessel dilation not assessable using TCD (3, 55) . The extracranial arteries supplying the brain are also sensitive to changes in CO2 levels and therefore contribute to cerebrovascular CO2 regulation. Images were acquired in accordance with methodological guidelines (47) and data analysed as previously reported (21) . To reduce any influence of turbulent flow on vascular responsiveness, the CCA was imaged at least two centimetres below the point of bifurcation. Data were used to determine the response of the CCA to elevations in PETCO2 by averaging 30-sec of baseline diameter and blood flow data and comparing that to the diameter and blood flow during the last 30-sec of 5% CO2 breathing. All ultrasound measurements were completed by the same sonographer, who has a between-day intraobserver coefficient of variation of 3.5% for the CCA, in line with methodological guidelines (47) .
Cerebral autoregulation (CA).
A second key factor determining adequate CBF is effective CA, which maintains CBF over a range of perfusion pressures (56 and high frequency (HF: 0.2-0.5 Hz) (13) . TFA is a frequency-dependent phenomenon and these domains are within the frequency range CA is thought to operate. CA is viewed as a highpass filter as the regulation of CBF is effective in the low frequency range of BP oscillations, but not in the high frequency range due to the time delay in initiating cerebrovascular adaptations to the changes in perfusion pressure (4) . CA therefore allows rapid BP changes to be transmitted to CBF, whereas slow BP changes are filtered (4) . As a consequence, the three frequency ranges have different responses and are likely controlled by different mechanisms
Gain is a measure of how changes in BP are transmitted into MCAv (12) . A low gain indicates efficient CA, with increases in gain consequently corresponding to reduced efficiency as for a given change in BP there are greater changes in MCAv (4). Phase describes the temporal relationship between changes in BP and MCAv (12) . Waveforms that are in sync are referred to as 'in phase', while if these waveforms are displaced from each other it describes a phase shift. Phase shift is considered a surrogate measure for the time delay of the autoregulatory response, with an increase in phase indicating a more efficient CA (4). Coherence describes the linearity of the relationship between the changes in MCAv and BP, with a coherence value approaching one indicating a linear relationship (4, 12) . Coherence values were used to accept the validity of gain and phase estimates, with cut-off values for inclusion set at 0.4 in accordance with published guidelines (13) . Analyses yielding coherence values lower than this cut-off value were excluded. As recommended, gain was normalised to control for possible baseline differences in BP and MCAv between conditions, therefore normalised gain was used during the interpretation of data (4, 13).
Hemodynamics. Participants were fitted with a photoplethysmographic cuff on the index or middle finger of the right hand (Finometer model 1, Finapres Medical Systems BV, Amsterdam,
The Netherlands) and a 3-lead electrocardiogram to continuously assess MAP and HR throughout measurements.
Statistical analyses
Data was analysed using statistical software (SPSS Version 22.0, IBM Corporation, Somers, NY, USA), with significance accepted as p≤0.05. Results are presented as means±standard error (SE). For each condition, the change in all outcomes parameters was calculated (4-hr-baseline, Δ). To assess differences between conditions, parameters were analysed using one-factor general linear mixed model with baseline values as a covariate. Differences in MCAv and HR between pre-walk and during each walk were analysed using paired samples t-tests. Post-hoc analyses were performed using the least significant difference (LSD) method.
RESULTS
Descriptive statistics are shown in Table 1 .
Intervention effects
Cardiorespiratory and haemodynamic measures.
There were no significant main effects for the change in supine (p=0.78) or seated (p=0.33)
MAP or the change in supine (p=0.90) or seated (p=0.82) HR (Table 2) . Additionally, no differences in the change in supine (p=0.30) or seated (p=0.61) PETCO2 were observed ( Table   2) .
Cerebral blood flow.
Values for MCAv are presented in Table 2 . A significant main effect was observed for the change in supine MCAv (p=0.048), with post hoc analysis revealing a greater change in MCAv during SIT compared to 2WALK (p=0.02; Figure 2a ), but not between SIT and 8WALK (p=0.14). Supine CVC however showed no significant main effect (p=0.09; Figure 2c ). Seated
MCAv showed a significant main effect (p=0.01), with significantly reduced MCAv observed in both SIT (p=0.01) and 8WALK (p=0.047) compared to 2WALK (Figure 2b ). Seated CVC also differed significantly between conditions (p=0.01), with post hoc analysis revealing the change in 2WALK was significantly different compared to SIT (p=0.03; Figure 2d ).
Cerebrovascular carbon dioxide reactivity.
Values of linear regression for MCA CVR are presented in Table 3 . No significant main effect (p=0.30) was observed for the change in CVR. There was also no significant main effect 8WALK Baseline: -0.51±0.82 ml.s -1 , 4hrs: -0.10±1.14 ml.s -1 ).
Cerebral Autoregulation.
Mean values for coherence for each of the frequency domains were: VLF 0.5; LF 0.6; HF 0.4. Table 4 presents values for phase, gain and normalised gain for each domain. A significant main effect was observed in the VLF for the change in phase (p=0.047) and gain (p=0.001). For phase, post hoc analyses showed the change in SIT was significantly lower than the change in 2WALK (p=0.02). For gain, the change in 8WALK was significantly less compared to the change in 2WALK (p=0.01). In the LF the main effect for normalised gain approached significance (p=0.05). No significant main effect was observed in the HF for any parameters (p>0.05).
Physiological responses during walking breaks
Mean treadmill speed for each condition and every walking break was 3.6 km/h at an RPE of 8.6.
2WALK.
Walking breaks increased MCAv in seven out of the eight breaks. are not directly comparable to exercise, our findings show that CA can be modified by low intensity PA and that this response is influenced by the frequency this activity.
CVR did not differ across the three conditions. Previous work has shown acute improvements in CVR following both moderate and strenuous intensity cycling for 50-min (34) . In contrast, in our study the walking break interventions had no effect on CVR. A potential explanation for our observation is that we used light intensity, short duration PA interventions rather than Workplace Application. As 65-75% of office workers' hours are spent sitting, the workplace has been identified as a key setting to reduce SB. However, as outlined by Buckley et al. (10), many health promotion and PA interventions aim to reduce SB by targeting moderate to vigorous PA, which is unlikely to be achievable within the constraints of a workplace. The frequent, light intensity walking break strategy used in our study is in line with recent workplace guidelines advising increasing light activity during working hours and regularly breaking up seated work (10) . Importantly, accumulating evidence suggests that light intensity PA is beneficially associated with biomarkers of cardiometabolic health and may reduce mortality risk (18) . Collectively this indicates that sedentary individuals should be encouraged to engage in PA of low intensities to confer improvements to health; such as by using the strategy employed in this study by interrupting prolonged sitting with light intensity walking breaks.
Limitations. Our study assessed the responses to a short sitting period, however of greater ecological interest would be examining the chronic responses to sitting. Whilst within an experimental visit we controlled the activities that participants completed during sitting so that 20 they were of a low-cognitive demand, these activities were not matched between visits. It is therefore possible that the activities they performed while seated differed between visits which may have influenced cerebrovascular responses. The use of TCD to assess MCAv and cerebrovascular function is associated with known limitations, including the inability to measure actual blood flow (54) , the assumptions that measures from the MCA are representative of other cerebral vessels (2) , and that MCA diameter is unaltered during varying levels of CO2 (46) . By recording the signal parameters and photographically recording the TCD probe placement, it was ensured as closely as possible the probe was in the same location and at the same angle for each visit; small variations may have occurred, however our coefficient of variation was 7.8% indicating good reproducibility. The analysis of CA using TFA is a developing method and lacks references values (13) . Therefore whilst current assessment and analysis guidelines were adhered to (13), future research is required to fully understand the clinical value of our results.
Conclusion and implications
For the first time this study demonstrates that in healthy desk workers prolonged, uninterrupted sitting impairs CBF, whilst these reductions are offset when frequent, short duration walking breaks are incorporated. These observations may have clinical importance for both cognition and disease risk. Acutely cognitive performance declines following transient carotid artery occlusion that decreases CBF (23), but increases following pharmacologically elevated CBF (16) . Given that UK office workers report sitting at work for 6.3-hr (25) , reductions in CBF may have important ramifications for workers' productivity. More importantly, chronic reductions in CBF is a risk factor for cognitive impairment (40) , is associated with cerebrovascular diseases such as Alzheimer's disease and dementia (41, 43, 58, 59 ) and correlates with cognitive dysfunction in Alzheimer's disease (38) . Consequently, in the long term the repeated exposure to sitting-induced decreases in CBF could cause chronic downregulation of CBF and therefore have large implications in the development of such diseases; which has previously been suggested (53) . The high prevalence of SB in these cerebrovascular disease populations further highlights the relevance of our findings. The maintenance of CBF using frequent walking breaks to interrupt sitting therefore represents a protective mechanism against disease risk. Indeed, in a nondemented cohort, greater CBF was associated with a decreased chance of dementia development and less cognitive decline over a 6.5 year follow-up (40) . Future work is needed to better understand the potential relation between SB and development of cerebrovascular diseases.
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